Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8241693 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusions: A group of patients at high risk for disease progression was identified, characterized by the downregulated stefin A protein in the tumor compared with the nontumorous mucosa. Stefin A was recognized as a promising candidate marker for prognosis in patients with operable carcinoma of the head and neck.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Primož M.D., Ph.D., Aleksandar M.D., M.Sc., Branka B.Sc., Maja B.Sc., Lojze M.D., Ph.D., Janko Ph.D.,